IHS Chemical Week

Regions :: Western Europe :: Germany

GSK Acquires Chemical Proteomics Company

1:13 AM MDT | May 16, 2012 | Deepti Ramesh

GlaxoSmithKline (GSK; London) says it has entered into an agreement to acquire those shares it does not currently own in privately held Cellzome (Heidelberg, Germany), a leader in the development and advancement of proteomics technologies, for £61 million ($97 million) in cash. The acquisition is expected to be completed on May 21, 2012. GSK, which currently owns a 19.98% equity interest in Cellzome, will assume full control of the company. Cellzome has laboratories at Cambridge, U.K.; and Heidelberg, and it will become part of GSK’s research &...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa